It was found that luteolin could inhibit the growth of thyroid cancer cells by reducing BRAF-activated non-protein coding RNA (BANCR) and thyroid stimulating hormone receptor (TSHR) (Liu et al., 2017; Du and Shen, 2023). The gene discussed is TSHR; the disease is thyroid gland carcinoma.